Trial · NCT03298867
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Were Proptosis Responders at Week 24 | Placebo | 9.5 | percentage of participants | ||
| Percentage of Participants Who Were Proptosis Responders at Week 24 | Teprotumumab 20 mg/kg | 82.9 | percentage of participants | ||
| Percentage of Participants Who Were Overall Responders at Week 24 | Placebo | 7.1 | percentage of participants | ||
| Percentage of Participants Who Were Overall Responders at Week 24 | Teprotumumab 20 mg/kg | 78.0 | percentage of participants | ||
| Percentage of Participants Who Were CAS Categorical Responders at Week 24 (Study Eye) | Placebo | 21.4 | percentage of participants | ||
| Percentage of Participants Who Were CAS Categorical Responders at Week 24 (Study Eye) | Teprotumumab 20 mg/kg | 58.5 | percentage of participants | ||
| Change From Baseline in Proptosis to Week 24 (Study Eye) | Placebo | -0.54 | Standard Error 0.192 | mm | |
| Change From Baseline in Proptosis to Week 24 (Study Eye) | Teprotumumab 20 mg/kg | -2.82 | Standard Error 0.191 | mm | |
| Percentage of Participants Who Were Diplopia Responders at Week 24 | Placebo | 28.6 | percentage of participants | ||
| Percentage of Participants Who Were Diplopia Responders at Week 24 | Teprotumumab 20 mg/kg | 67.9 | percentage of participants | ||
| Change From Baseline in the Graves' Ophthalmopathy Quality of Life (GO-QoL) Questionnaire Overall Score to Week 24 | Placebo | 4.43 | Standard Error 2.102 | score on a scale | |
| Change From Baseline in the Graves' Ophthalmopathy Quality of Life (GO-QoL) Questionnaire Overall Score to Week 24 | Teprotumumab 20 mg/kg | 13.79 | Standard Error 2.074 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03298867/results